Janet DeLeon is the Co-Founder and CEO of Etienna Bio, a regenerative biotechnology company. With extensive experience in pharmaceutical product development and FDA regulations, she now leads the translation of a novel stem cell platform for aesthetic and reconstructive medicine. Colleagues describe her as knowledgeable, proactive, and a good communicator.
She earned a BS from Quincy University and holds a Regulatory Affairs Certification.
Janet is pioneering a dual-output stem cell platform that generates both adipose tissue and collagen from a single patient sample, creating natural alternatives to synthetic fillers.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.